BiotechTube
Beeken Biomedical

Beeken Biomedical

Austin, United States· Est.
beekenbiomedical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5.3M

Overview

Beeken Biomedical, founded in 2015, is a private medical device company specializing in advanced hemostatic solutions. Its flagship NuStat® product line, built on a patented Hemafiber™ technology, is indicated for temporary control of severe internal organ space bleeding (Class III/IV) and traumatic wounds. The company targets both the hospital/acute care market and the public safety/first responder sector with products that require no preparation and are designed for rapid application. Beeken is commercial-stage, holding key regulatory certifications including MDSAP (ISO 13485:2016).

HemostasisTraumaSurgical Bleeding

Technology Platform

Patented Hemafiber™ technology: a matrix of hemostatic clotting fibers that accelerate clot formation through absorption and local concentration of the patient's own clotting factors at the wound site.

Funding History

2
Total raised:$5.3M
Seed$2.8M
Seed$2.5M

Opportunities

The growing 'Stop the Bleed' initiative and increased public safety mandates create a large, expanding market for easy-to-use hemostatic products.
Furthermore, the specific FDA clearance for internal organ space bleeding opens doors in the high-value hospital surgical market where controlling severe hemorrhage is critical.

Risk Factors

Intense competition from large, established medtech companies and other hemostatic device startups poses a significant market penetration challenge.
As a small, private company, Beeken also faces risks related to limited financial resources for scaling sales efforts and dependence on securing large government or institutional contracts.

Competitive Landscape

Beeken competes in the broad hemostat market against giants like Johnson & Johnson (Ethicon) with SURGICEL and Baxter with FLOSEAL, as well as specialized players like Z-Medica (QuikClot), RevMedx (XSTAT), and CryoLife. Differentiation is based on mechanism (factor concentration vs. active agents), ease of use, indication set, and price.

More companies in Drug Delivery & Formulation →More companies in United States →